国際オンライン医療評議会 (IOMC) | 医学研究

GET THE APP

抽象化/インデックス化

Jゲート開いて、ゲノミクス、 グーグル スカラー、ISA (インド科学抄録)、CAS (化学抄録サービス)、CABI (英国)、インデックスコペルニクス、ヒナリ、エブスコ、ウルリッヒの定期編集物ディレクトリ、植物農薬、雑草抄録、 アグバイオテックネット、獣医師リソース、作物生理学抄録、アグロフォレストリー抄録、蠕虫学抄録トラクト、観賞用園芸、植物遺伝資源の概要、豚のニュースと情報、酪農科学の概要、農業経済データベース、寄生虫学データベース、CAB概要、動物記録、収穫後のニュースと情報、栄養と食品科学のデータベース、有機データベース、グローバル、ヘルス、ABC化学、サイエンスセントラル、シマゴなど、さらに多くのデータが処理中です。

付加価値の概要

Data-driven statistical modeling and analysis of the survival times of multiple myeloma(mm) cancer.

Lohuwa Mamudu

Multiple Myeloma (MM) cancer has been and continues
to be the subject of many research studies. The main goal
is to improve the therapeutic/treatment process of th..もっと見る»

付加価値の概要

Personalized and Precision Medicine (PPM) as a Unique Healthcare Model to Be Set Up via Translational Applications and Upgraded Business Modeling to Secure the Human Healthcare, Wellness and Biosafety

Sergey Suchkov

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). To achieve the imple..もっと見る»

短いコミュニケーション

Coronavirus impacts on Respiratory System and its Phases

Andrea Biscardi

While Covid-19 pandemic sweeps across the globe, it is important to understand the transmission and the effect of the virus which has made it a pandemic .Coronavirus has a place..もっと見る»

抄録

Management of dental fluorosis: What about ceramic veneers?

Nissaf Daouahi

Dental fluorosis is a dental enamel defect caused by excessive systemic use of fluoride during tooth development.  Depending on the dental fluorosis severity, several optio..もっと見る»

意見

Contextualizing Juvenile Primary Mental Health: Environmental Determinants and Emotional Well-Being Results

Annie Johnson

The spatiotemporal gathering level examples of cerebrum macrostructural improvement are generally very much recorded. Momentum research accentuates individual fluctuation in men..もっと見る»

短いコミュニケーション

Benefit-Risk of Immunomodulators in Multiple Sclerosis. Alemtuzumab and Next?

Francois Curtin

End of December 2013, alemtuzumab, a monoclonal antibody for multiple sclerosis (MS) with an immunomodulator
action targeting CD52 receptors and inducing decrease counts ..もっと見る»